Rudolf Bucci
Family · Cheektowaga, NYNPI 1003954140
Payments from drug & device makers
Across 363 payments — averaging $17.48 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$1K
- Mannkind Corporation$909
- Lilly USA, LLC$829
- Exact Sciences$385
- Sanofi-aventis U.S. LLC$385
- AstraZeneca$334
- plus $2K from 26 others
What the payments were for
- Food & beverage$6,22998%
- Education$571%
- Gifts$591%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 106 | $1,379 |
| Mannkind Corporation | 32 | $909 |
| Lilly USA, LLC | 46 | $829 |
| Exact Sciences | 21 | $385 |
| Sanofi-aventis U.S. LLC | 24 | $385 |
| AstraZeneca | 19 | $334 |
| Insulet Corporation | 17 | $302 |
| AbbVie | 17 | $300 |
| Boehringer Ingelheim | 10 | $162 |
| Grifols USA, LLC | 9 | $162 |
| Dexcom, Inc. | 8 | $152 |
| GSK | 7 | $118 |
| Amgen | 5 | $101 |
| Merck | 5 | $96 |
| Bayer | 5 | $92 |
| Amarin Pharma, Inc. | 5 | $86 |
| Ascendis Pharma Endocrinology Inc | 3 | $84 |
| Amneal Pharmaceuticals LLC | 3 | $77 |
| Abbott | 3 | $54 |
| Amphastar Pharmaceuticals, Inc. | 3 | $46 |
| Medtronic | 2 | $44 |
| Corcept Therapeutics | 2 | $35 |
| Ultragenyx Pharmaceutical Inc. | 2 | $32 |
| Neurocrine Biosciences, Inc. | 1 | $30 |
| Inspire Medical Systems, Inc. | 1 | $29 |
| Pfizer | 1 | $27 |
| Sequel Med Tech, LLC | 1 | $21 |
| Eisai Inc. | 1 | $19 |
| Daiichi Sankyo Inc. | 1 | $19 |
| Esperion Therapeutics, Inc. | 1 | $14 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $13 |
| Cequr Corporation | 1 | $8 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$6,345 in reported general payments places this provider in the 95th percentile of 8,883 family providers in New York.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 111 | $174,468 |
| JardianceEmpagliflozin | 148 | $146,900 |
| Tresiba Flextouch U-200Insulin Degludec | 47 | $95,977 |
| Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog | 41 | $71,609 |
| TrulicityDulaglutide | 36 | $65,256 |
| FarxigaDapagliflozin Propanediol | 62 | $58,249 |
| RybelsusSemaglutide | 24 | $26,586 |
| TradjentaLinagliptin | 17 | $19,944 |
| MounjaroTirzepatide | 16 | $19,868 |
| Tresiba Flextouch U-100Insulin Degludec | 27 | $17,906 |
| Humalog Kwikpen U-100Insulin Lispro | 59 | $17,492 |
| Toujeo SolostarInsulin Glargine,hum.Rec.Anlog | 17 | $14,993 |
| JanuviaSitagliptin Phosphate | 22 | $14,133 |
| Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog | 30 | $11,452 |
| Humalog Mix 75-25 KwikpenInsulin Lispro Protamin/Lispro | 15 | $11,160 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic, Rybelsus | $1,379 | $201,054135 claims |
| Boehringer IngelheimJardiance, Tradjenta | $162 | $166,844165 claims |
| Lilly USA, LLCTrulicity, Mounjaro | $829 | $85,12452 claims |
| AstraZenecaFarxiga | $334 | $58,24962 claims |
| MerckJanuvia | $96 | $14,13322 claims |
| PfizerEliquis | $27 | $10,54619 claims |
| AbbVieSynthroid | $300 | $7,366103 claims |
| Amneal Pharmaceuticals LLCLevothyroxine Sodium | $77 | $6,525442 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 8,883 family providers in New York.
Other family in Cheektowaga
- Christina NalboneNew York$197K
- Casey GrilloNew York$191K
- Suzanne WilsonIthaca$179K
- Jonathan LesuerSyracuse$172K
- Sheri HillNorth Syracuse$165K
- Cathrine CurtinBronxville$155K
- Mary Sullivan-WhalenNew York$137K
- Sarah AljahmiRockville Centre$87K
- John de OcaStaten Island$86K
- Fara StrickerGlen Oaks$85K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.